Vitamin D

Present Knowledge in Nutrition: Tenth Edition

Volumn , Issue , 2012, Pages 199-213

  Norman, Anthony W ^a   Henry, Helen L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemistry and irradiation pathway for vitamin D3 production; Chemistry of vitamin D, vitamin D3 (cholecalciferol) and its provitamin; Newly expanded vitamin D endocrine systems, five new physiological systems; Vitamin D endocrine system, an updated understanding; Vitamin D endocrine system, plasma vitamin DBP, carrying vitamin D; Vitamin D metabolism, vitamin D3 into two key metabolites; Vitamin D nutritional status, best markers as levels of serum 25(OH)D; Vitamin D supplementation on vitamin D toxicity frequency, severity; Vitamin D, its biologically active metabolite effect on human diseases; Vitamin D, targeting tissues, than just the calcium homeostasis related

Indexed keywords

EID: 84886976251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119946045.ch13     Document Type: Chapter

References (77)

1. Armas, L.A.G., Hollis, B.W., and Heaney, R.P. (2004) Vitamin D 2 is much less effective than vitamin D 3 in humans. J Clin Endocrinol Metab 89, 5387-5391.
2. Barger-Lux, M.J. and Heaney, R.P. (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87, 4952-4956.
3. Beckman, M.J., Johnson, J.A., Goff, J.P., et al. (1995) The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D 3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 319, 535-539.
4. Bischoff-Ferrari, H.A., Dawson-Hughes, B., Staehelin, H.B., et al. (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. Br Med J 339, b3692.
5. Bouillon, R. (2009) Vitamin D as potential baseline therapy for blood pressure control. Am J Hypertens 22, 867-870.
6. Bouillon, R., Carmeliet, G., Verlinden, L., et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrinol Rev 29, 726-776.
7. Bouillon, R., Okamura, W.H., and Norman, A.W. (1995) Structure-function relationships in the vitamin D endocrine system. Endocrinol Rev 16, 200-257.
8. Bouillon, R., Verstuyf, A., Mathieu, C., et al. (2006) Vitamin D resistance. Best Pract Res Clin Endocrinol Metab 20, 627-645.
9. Bula, C.M., Huhtakangas, J., Olivera, C.J., et al. (2005) Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 146, 5581-5586.
10. Feldman, D., Pike, J.W., and Glorieux, F.H. (2005) (eds) Vitamin D, 2nd Edn. Elsevier Academic Press, San Diego.
11. Garland, C.F., Gorham, E.D., Mohr, S.B., et al. (2007) Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103, 708-711.
12. Giovannucci, E., Liu, Y., Rimm, E.B., et al. (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451-459.
13. Harris, S.S. and Dawson-Hughes, B. (1998) Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr 67, 1232-1236.
14. Hathcock, J.N., Shao, A., Vieth, R., et al. (2007) Risk assessment for vitamin D. Am J Clin Nutr 85, 6-18.
15. Haussler, M.R. and Norman, A.W. (1969) Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62, 155-162.
16. Haussler, M.R., Myrtle, J.F., and Norman, A.W. (1968) The association of a metabolite of vitamin D 3 with intestinal mucosa chromatin, in vivo. J Biol Chem 243, 4055-4064.
17. Heaney, R.P. and Holick, M.F. (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res PMID 21207378.
18. Heaney, R.P., Recker, R.R., Grote, J., et al. (2011) Vitamin D 3 is more potent than vitamin D 2 in humans. J Clin Endocrinol Metab 96, E447-452. PMID 21177785.
19. Henry, H.L. (2000) Vitamin D. In H.M. Goodman (ed.), Handbook of Physiology, Section 7: The Endocrine System. Oxford University Press, New York, pp. 699-718.
20. Henry, H.L. (2001) The 25(OH)D 3 /1 α,25(OH) 2 D 3-24R-hydroxylase: a catabolic or biosynthetic enzyme? Steroids 66, 391-398.
21. Henry, H.L. (2005) The 25-hydroxyvitamin D3-1a-hydroxylase in vitamin D. In D. Feldman, F.H. Glorieux, and J.W. Pike (eds),Vitamin D, 2nd Edn. Academic Press, San Diego, pp. 69-83.
22. Henry, H.L. and Norman, A.W. (1978) Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 201, 835-837.
23. Henry, H.L., Bouillon, R., Norman, A.W., et al. (2010) 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 121, 4-6.
24. Henry, H.L., Dutta, C., Cunningham, N., et al. (1992) The cellular and molecular regulation of 1,25(OH) 2 D 3 production. J Steroid Biochem Mol Biol 41, 401-407.
25. Holick, M.F., Biancuzzo, R.M., Chen, T.C., et al. (2008) Vitamin D2 is as effective as vitamin D 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677-681
26. Huhtakangas, J.A., Olivera, C.J., Bishop, J.E., et al. (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 α,25(OH) 2-vitamin D 3 in vivo and in vitro. Mol Endocrinol 18, 2660-2671.
27. Institute of Medicine (1997) Dietary Reference Intakes for Calcium, Magnesium, Phosphorus, Vitamin D, and Fluoride. National Academies Press, pp. 250-287.
28. Institute of Medicine (2011) Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, DC. http://books.nap.edu/openbook.php?record-id=13050.
29. IUPAC (1960) Definitive rules for the nomenclature of amino acids, steroids, vitamins, and carotenoids. J Am Chem Soc 82, 5575-5586.
30. Jacobus, C.H., Holick, M.F., Shao, Q., et al. (1992) Hypervitaminosis D associated with drinking milk. New Engl J Med 326, 1173-1177.
31. Kitanaka, S., Takeyama, K., Murayama, A., et al. (1998) Inactivating mutations in the 25-hydroxyvitamin D 3 1 α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338, 653-661.
32. Kreiter, S.R., Schwartz, R.P., Kirkman, H.N., Jr, et al. (2000) Nutritional rickets in African American breast-fed infants. J Pediatr 137, 153-157.
33. Laing, C.J. and Cooke, N.E. (2005) Vitamin D binding protein. In D. Feldman, F.H. Glorieux, and J.W. Pike (eds), Vitamin D, 2nd Edn. Elsevier Academic Press, San Diego, pp. 117-134.
34. Lips, P. (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103, 620-625.
35. Mangelsdorf, D.J., Thummel, C., Beato, M., et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
36. Mawer, E.B., Stanbury, S.W., Robinson, M.J., et al. (1986) Vitamin D nutrition and vitamin D metabolism in the premature human neonate. Clin Endocrinol (Oxf) 25, 641-649.
37. Melamed, M.L., Michos, E.D., Post, W., et al. (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168, 1629-1637.
38. Michos, E.D. and Blumenthal, R.S. (2007) Vitamin D supplementation and cardiovascular disease risk. Circulation 115, 827-828.
39. Mizwicki, M. and Norman, A.W. (2009) The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal 2, re4. PMID 19531804.
40. Mizwicki, M.T., Keidel, D., Bula, C.M., et al. (2004) Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH) 2-vitamin D 3 signaling. Proc Natl Acad Sci USA 101, 12876-12881.
41. Mizwicki, M.T., Menegaz, D., Yaghmaei, S., et al. (2010) A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications. J Steroid Biochem Mol Biol 121, 98-105.
42. Munger, K.L., Levin, L.I., Hollis, B.W., et al. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832-2838.
43. Norman, A.W. (1979) Vitamin D: The Calcium Homeostatic Steroid Hormone, 1st Edn. Academic Press, New York.
44. Norman, A.W. (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147, 5542-5548.
45. Norman, A.W. and Bouillon, R. (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med 235, 1034-1045.
46. Norman, A.W. and Henry, H.L. (2003) Vitamin D: 24,25-dihydroxy vitamin D. In H.L. Henry and A.W. Norman (eds), Encyclopedia of Hormones. Academic Press, San Diego, pp. 635-638.
47. Norman, A.W. and Litwack, G. (1987) Hormones. Academic Press, Orlando, FL.
48. Norman, A.W., Bouillon, R., Whiting, S.J., et al. (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103, 204-205.
49. Norman, A.W., Henry, H.L., and Malluche, H.H. (1980) 24R,25-dihydroxyvitamin D 3 and 1 α,25-dihydroxyvitamin D 3 are both indispensable for calcium and phosphorus homeostasis. Life Sci 27, 229-237.
50. Norman, A.W., Leathers, V.L., and Bishop, J.E. (1983) Studies on the mode of action of calcifer. XLVIII. Normal egg hatchability requires the simultaneous administration to the hen of 1α,25-dihydroxyvitamin D 3 and 24R,25-dihydroxyvitamin D3. J Nutr 113, 2505-2515.
51. Norman, A.W., Mizwicki, M.T., and Norman, D.P.G. (2004) Steroid hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3, 27-41.
52. Norman, A.W., Myrtle, J.F., Midgett, R.J., et al. (1971) 1,25-Dihydr oxycholecalciferol: identification of the proposed active form of vitamin D 3 in the intestine. Science 173, 51-54
53. Norman, A.W., Okamura, W.H., Farach-Carson, M.C., et al. (1993) Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine syste. 1,25-dihydroxy-pentadeuterio-previtamin D 3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. J Biol Chem 268, 13811-13819.
54. Ochs-Balcom, H.M., Chennamaneni, R., Millen, A.E., et al. (2011) Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr 93, 5-10.
55. Pike, J.W. and Shevde, N.K. (2005) The vitamin D receptor. In D. Feldman, F.H. Glorieux, and J.W. Pike (eds), Vitamin D, 2nd Edn. Academic Press, San Diego, pp. 167-191.
56. Pittas, A.G., Lau, J., Hu, F.B., et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029.
57. Schwartz, Z., Sylvia, V.L., Larsson, D., et al. (2002) 1 α,25(OH) 2 D 3 regulates chondrocyte matrix vesicle protein kinase D (PKC) directly via G protein-dependent mechanisms and indirectly via incorporation of PKC during matrix vexicle biogenesis. J Biol Chem 277, 11828-11837.
58. Seo, E-G., Einhorn, T.A., and Norman, A.W. (1997) 24R,25-Dihydroxyvitamin D 3:an essential vitamin D 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138, 3864-3872.
59. Shea, M.K., Booth, S.L., Massaro, J.M., et al. (2008) Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 167, 313-320.
60. St-Arnaud, R. (2010) CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol 121, 254-256.
61. Talat, N., Perry, S., Parsonnet, J., et al. (2010) Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 16, 853-855.
62. Thacher, T.D. and Clarke, B.L. (2011) Vitamin D insufficiency. Mayo Clin Proc 86, 50-60.
63. Thacher, T.D., Fischer, P.R., Petitfor, J.M., et al. (1999) A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 341, 563-568.
64. Trang, H., Cole, D.E., Rubin, L.A., et al. (1998) Evidence that vitamin D 3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D 3. Am J Clin Nutr 68, 854-858.
65. Vazquez, G., De Boland, A.R., and Boland, R.L. (1998) 1 α,25-Dihydroxy-vitamin-D 3-induced store-operated Ca 2+ influx in skeletal muscle cells-modulation by phospholipase C, protein kinase C, and tyrosine kinases. J Biol Chem 273, 33954-33960.
66. Vertino, A.M., Bula, C.M., Chen, J-R., et al. (2005) Nongenotropic, and anti-apoptotic signaling of vitamin D analogs through the ligand binding domain (LBD) of the vitamin D receptor (VDR) in osteoblasts and osteocytes: mediation by Src, P13 and JNK kinases. J Biol Chem 280, 14130-14137.
67. Vieth, R. (2004) Why the optimal requirement for vitamin D 3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90, 575-579.
68. Vieth, R., Cole, D.E., Hawker, G.A., et al. (2001) Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 55, 1091-1097
69. Weatherman, R.V., Fletterick, R.J., and Scanlon, T.S. (1999) Nuclear receptor ligands and ligand-binding domains. Annu Rev Biochem 68, 559-582.
70. Webb, A.R. and Holick, M.F. (1988) The role of sunlight in the cutaneous production of vitamin D 3. Annu Rev Nutr 8, 375-399.
71. Whitfield, G.K., Jurutka, P.W., Haussler, C.A., et al. (2005) Nuclear vitamin D receptor: structure-function, molecular control of gene transcription and novel bioactions. In D. Feldman, F.H. Glorieux, and J.W. Pike (eds), Vitamin D, 2nd Edn. Academic Press, San Diego, pp. 219-328.
72. Williams, B., Williams, A.J., and Anderson, S.T. (2008) Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 27, 941-942.
73. Wolf, M., Betancourt, J., Chang, Y., et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19, 1379-1388
74. Wright, J.W. (ed.) (2010) World population. New York Times 2010 Almanac. Penguin Books, London, pp. 484-486.
75. Zanello, L.P. and Norman, A.W. (1997) Stimulation by 1 α, 25(OH)2-vitamin D 3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells: a structure-function study. J Biol Chem 272, 22617-22622.
76. Zanello, L.P. and Norman, A.W. (2004) Rapid modulation of osteoblast ion channel responses by 1 α,25(OH) 2-vitamin D 3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101, 1589-1594.
77. Zeitz, U., Weber, K., Soegiarto, D.W., et al. (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17, 509-511.